Tommaso Sconocchia Division of Hematology, Department of Internal Medicine Medical University of Graz Biography Publications Institution JoVE Articles Tommaso Sconocchia has not added a biography. If you are Tommaso Sconocchia and would like to personalize this page please email our Author Liaison for assistance. Publications Human Gene-engineered Calreticulin Mutant Stem Cells Recapitulate MPN Hallmarks and Identify Targetable Vulnerabilities Leukemia. Feb, 2023 | Pubmed ID: 36813992 Direct CD32 T-cell Cytotoxicity: Implications for Breast Cancer Prognosis and Treatment Life Science Alliance. Dec, 2022 | Pubmed ID: 36241426 Immunomodulatory Effects of Aronia Juice Polyphenols-Results of a Randomized Placebo-Controlled Human Intervention Study and Cell Culture Experiments Antioxidants (Basel, Switzerland). Jun, 2022 | Pubmed ID: 35883769 Immunotherapy As a Turning Point in the Treatment of Acute Myeloid Leukemia Cancers. Dec, 2021 | Pubmed ID: 34944865 Regulation of the Immune System in Health and Disease by Members of the Bone Morphogenetic Protein Family Frontiers in Immunology. 2021 | Pubmed ID: 34925388 The MiR-424(322)/503 Gene Cluster Regulates Pro- Versus Anti-inflammatory Skin DC Subset Differentiation by Modulating TGF-β Signaling Cell Reports. Apr, 2021 | Pubmed ID: 33910004 Induction of the Sphingosine-1-phosphate Signaling Pathway by TGF-β1 During Langerhans-type Dendritic Cell Differentiation European Journal of Immunology. Jul, 2021 | Pubmed ID: 33768654 Bone Morphogenetic Protein Signaling Regulates Skin Inflammation Via Modulating Dendritic Cell Function The Journal of Allergy and Clinical Immunology. May, 2021 | Pubmed ID: 33250156 BMP7 Aberrantly Induced in the Psoriatic Epidermis Instructs Inflammation-associated Langerhans Cells The Journal of Allergy and Clinical Immunology. Apr, 2020 | Pubmed ID: 31870764 In Vitro Elimination of Epidermal Growth Factor Receptor-overexpressing Cancer Cells by CD32A-chimeric Receptor T Cells in Combination with Cetuximab or Panitumumab International Journal of Cancer. Jan, 2020 | Pubmed ID: 31479522 CD16-158-valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab International Journal of Cancer. May, 2020 | Pubmed ID: 31396956 Recent Perspective on CAR and Fcγ-CR T Cell Immunotherapy for Cancers: Preclinical Evidence Versus Clinical Outcomes Biochemical Pharmacology. Aug, 2019 | Pubmed ID: 31176617 Engenharia de Mutações de Ganho de Função Heterozigotas Oncogênicas em Células-Tronco Hematopoiéticas Humanas e Progenitoras Tommaso Sconocchia1, Johannes Foßelteder1, Thomas Köhnke2, Ravindra Majeti2, Andreas Reinisch1,3 1Division of Hematology, Department of Internal Medicine, Medical University of Graz, 2Division of Hematology, Stanford Cancer Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 3Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz JoVE 64558 Cancer Research
Engenharia de Mutações de Ganho de Função Heterozigotas Oncogênicas em Células-Tronco Hematopoiéticas Humanas e Progenitoras Tommaso Sconocchia1, Johannes Foßelteder1, Thomas Köhnke2, Ravindra Majeti2, Andreas Reinisch1,3 1Division of Hematology, Department of Internal Medicine, Medical University of Graz, 2Division of Hematology, Stanford Cancer Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 3Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz JoVE 64558 Cancer Research
